Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07577310 · ClinicalTrials.gov registry record · NA

False Vocal Fold vs EMG Guided Botox for Vocal Tremor

A NA study, sponsored by University of Alabama at Birmingham.

Not yet
Registry status
NA
Development phase
30
Enrollment target

NCT07577310 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07577310, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.

NOT YET RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This is a prospective, non-randomized, two-arm comparative clinical trial evaluating outcomes of false vocal fold (FVF) botulinum toxin injections versus standard EMG-guided botulinum toxin injections in patients with essential voice tremor. Participants will receive either FVF injections or EMG-guided injections based on shared clinical decision-making between the treating laryngologist and patient. The study will assess changes in voice-related quality of life, tremor severity, and patient satisfaction over a 12-week follow-up period and compare these outcomes between the two treatment approaches.

Interventions

  • PROCEDURE False Vocal Fold (FVF) botulinum toxin injections
  • PROCEDURE Electromyography (EMG)-Guided Injection

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-08
Est. Completion 2030-07
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07577310

The ClinicalTrials.gov registry entry for NCT07577310 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which False Vocal Fold (FVF) botulinum toxin injections is the first listed.

NCT07577310 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07577310 about?

NCT07577310 is a clinical study titled "False Vocal Fold vs EMG Guided Botox for Vocal Tremor". This is a prospective, non-randomized, two-arm comparative clinical trial evaluating outcomes of false vocal fold (FVF) botulinum toxin injections versus standard EMG-guided botulinum toxin injections in patients with essential voice tremor. Participants will receive either FVF injections or EMG-gui...

What is the current status of trial NCT07577310?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-08. Estimated completion is 2030-07.

What interventions are being tested in trial NCT07577310?

The interventions under investigation include: False Vocal Fold (FVF) botulinum toxin injections (PROCEDURE), Electromyography (EMG)-Guided Injection (PROCEDURE).

Who is sponsoring clinical trial NCT07577310?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.